HNPCC (Colon Cancer)
Hunter Payne 1
References
1. Cancer of the colon and rectum - cancer stat facts. Surveillance, Epidemiology, and End
Results Program . https://seer.cancer.gov/statfacts/html/colorect.html. Accessed February 23,
2021.
2. Genetics of Colorectal Cancer (PDQ®)–Health Professional Version. National Cancer
Institute. https://www.cancer.gov/types/colorectal/hp/colorectal-genetics-pdq. Accessed
February 23, 2021.
3. Ye B, Stary CM, Gao Q, et al. Genetically Modified T-Cell-Based Adoptive Immunotherapy
in Hematological Malignancies. Journal of Immunology Research. 2017;2017:1-13.
doi:10.1155/2017/5210459
4. About Colon Cancer. Genome.gov. https://www.genome.gov/Genetic-Disorders/Colon-
Cancer. Accessed February 24, 2021.
5. Medical Options. Centers for Disease Control and Prevention.
https://www.cdc.gov/genomics/disease/colorectal_cancer/medical_options.htm. Published
September 13, 2018. Accessed February 24, 2021.
6. Colon Cancer Treatment, by Stage: How to Treat Colon Cancer. American Cancer Society.
https://www.cancer.org/cancer/colon-rectal-cancer/treating/by-stage-colon.html#references.
Published June 29, 2020. Accessed February 25, 2021.
7. Biller LH, Syngal S, Yurgelun MB. Recent advances in Lynch syndrome. Familial Cancer.
2019;18(2):211-219. doi:10.1007/s10689-018-00117-1
8. Boland PM, Yurgelun MB, Boland CR. Recent progress in Lynch syndrome and other
familial colorectal cancer syndromes. CA: A Cancer Journal for Clinicians. 2018;68(3):217-
231. doi:10.3322/caac.21448
Hunter Payne 2
9. Pathak SJ, Mueller JL, Okamoto K, et al. EPCAMmutation update: Variants associated with
congenital tufting enteropathy and Lynch syndrome. Human Mutation. 2018;40(2):142-161.
doi:10.1002/humu.23688
10. Burn J, Sheth H, Elliott F, et al. Cancer prevention with aspirin in hereditary colorectal
cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2
study: a double-blind, randomised, placebo-controlled trial. The Lancet.
2020;395(10240):1855-1863. doi:10.1016/s0140-6736(20)30366-4